
Itacitinib monotherapy for GVHD, the role of ERG in EVI1-driven AML, and germline DDX41 mutations in myeloid neoplasms
Blood Podcast
00:00
ERG Inhibitors in Acute Myeloid Neoplasms
The finding that EVI-1 rearranged AML cell lines were not equally sensitive to knockdown is also very interesting. Lopez and Mersher highlight the therapeutic implications of these findings. They believe that specific inhibition of ERG activity will likely be of wider therapeutic interest for several subtypes of aggressive AML.
Transcript
Play full episode